LeMaitre Vascular Inc (LMAT)
Gross profit margin
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross profit (ttm) | US$ in thousands | 149,429 | 142,616 | 136,253 | 131,343 | 125,561 | 119,838 | 114,093 | 109,817 | 104,896 | 104,798 | 104,594 | 103,545 | 101,382 | 99,828 | 97,666 | 87,934 | 84,618 | 80,124 | 77,586 | 80,872 |
Revenue (ttm) | US$ in thousands | 219,863 | 213,029 | 205,621 | 199,887 | 193,484 | 185,555 | 177,172 | 169,165 | 161,651 | 160,200 | 159,540 | 158,102 | 154,424 | 152,469 | 150,517 | 134,698 | 129,366 | 121,988 | 114,672 | 119,304 |
Gross profit margin | 67.96% | 66.95% | 66.26% | 65.71% | 64.89% | 64.58% | 64.40% | 64.92% | 64.89% | 65.42% | 65.56% | 65.49% | 65.65% | 65.47% | 64.89% | 65.28% | 65.41% | 65.68% | 67.66% | 67.79% |
December 31, 2024 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $149,429K ÷ $219,863K
= 67.96%
The gross profit margin of LeMaitre Vascular Inc has shown relative stability over the years, starting at around 67.79% in March 2020 and fluctuating within the range of 64.40% to 67.96% up to December 2024. The company's ability to maintain gross profit margins above 65% indicates strong pricing power, efficient cost management, and effective production processes. Overall, the consistent gross profit margins suggest that LeMaitre Vascular Inc has been effectively managing its production costs and pricing strategies to generate sufficient profits from its sales.
Peer comparison
Dec 31, 2024
Company name
Symbol
Gross profit margin
LeMaitre Vascular Inc
LMAT
67.96%
3M Company
MMM
45.86%
Artivion Inc
AORT
62.02%
Baxter International Inc
BAX
37.11%
Becton Dickinson and Company
BDX
12.72%
Boston Scientific Corp
BSX
67.02%
DexCom Inc
DXCM
60.41%
Embecta Corp
EMBC
65.81%
Glaukos Corp
GKOS
77.41%
Globus Medical
GMED
55.35%
Haemonetics Corporation
HAE
26.64%